Publications

Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study.

KANG, H; AUZENBERGS, M; Clapham, H; Maure, C; Kim, J-H; Salje, H; Taylor, CG; LIM, A; CLARK, A; EDMUNDS, WJ; Sahastrabuddhe, S; BRADY, OJ; ABBAS, K;

2024

The Lancet Infectious Diseases, (2024).24 5 10.1016/S1473-3099(23)00810-1.

Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.

Antony Oliver, MC; Graham, M; Gass, KM; MEDLEY, GF; Clark, J; Davis, EL; Reimer, LJ; King, JD; Pouwels, KB; Hollingsworth, TD;

2024

Clinical infectious diseases, (2024).78 Supple 10.1093/cid/ciae108.

Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.

GBD 2021 Forecasting Collaborators,;

2024

Lancet (London, England), (2024).403 10440 10.1016/S0140-6736(24)00685-8.

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

RUSSELL, TW; Townsley, H; Hellewell, J; Gahir, J; Shawe-Taylor, M; Greenwood, D; HODGSON, D; Hobbs, A; Dowgier, G; Penn, R; SANDERSON, T; Stevenson-Leggett, P; Bazire, J; Harvey, R; Fowler, AS; Miah, M; Smith, C; Miranda, M; Bawumia, P; Mears, HV; Adams, L; Hatipoglu, E; O'Reilly, N; Warchal, S; Ambrose, K; ... KUCHARSKI, AJ.

2024

The Lancet. Infectious diseases, (2024).0 0 10.1016/S1473-3099(24)00484-5.

Effects of sequential vs single pneumococcal vaccination on cardiovascular diseases among older adults: a population-based cohort study.

Tong, X; Gao, L; Wong, IC K; Chan, VK Y; WONG, AY S; Mak, JC W; Yuen, JK Y; JIT, M; Hung, IF N; Yiu, KH; Li, X;

2024

International journal of epidemiology, (2024).53 1 10.1093/ije/dyae005.

Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?.

Vasconcelos, A; King, JD; Nunes-Alves, C; Anderson, R; Argaw, D; Basáñez, M-G; Bilal, S; Blok, DJ; Blumberg, S; Borlase, A; BRADY, OJ; Browning, R; Chitnis, N; Coffeng, LE; Crowley, EH; Cucunubá, ZM; Cummings, DA T; Davis, CN; Davis, EL; Dixon, M; Dobson, A; Dyson, L; French, M; Fronterre, C; Giorgi, E; ... Fall, IS.

2024

Clinical infectious diseases, (2024).78 Supple 10.1093/cid/ciae082.

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a syst...

GBD 2021 Diseases and Injuries Collaborators,;

2024

Lancet (London, England), (2024).403 10440 10.1016/S0140-6736(24)00757-8.

Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study.

Krauer, F; Guenther, F; Treskova-Schwarzbach, M; Schoenfeld, V; Koltai, M; JIT, M; Hodgson, D; Schneider, U; Wichmann, O; Harder, T; Sandmann, F; FLASCHE, S;

2024

medRxiv (2024). 10.1101/2024.06.20.24309248.

Interview Questions for WW Dashboards.

O'REILLY, KM;

2024

, Zenodo (2024).

Modelling spatiotemporal patterns of visceral leishmaniasis incidence in two endemic states in India using environment, bioclimatic and demographic data, 2013-2022.

Subramanian, S; Maheswari, RU; Prabavathy, G; Khan, MA; Brindha, B; Srividya, A; Kumar, A; Rahi, M; NIGHTINGALE, ES; MEDLEY, GF; CAMERON, MM; Roy, N; Jambulingam, P;

2024

PLoS neglected tropical diseases, (2024).18 2 10.1371/journal.pntd.0011946.